Tasigna International Website 
For Healthcare Professionals Outside the U.S.
U.S. Residents
 
  • larger text larger text   
  • E-mail this pages
  • print this page print this page
Back to Web Page  |  Print This Page
  
Search
Stay Informed
Get updates on clinical data, Ph+ CML news and upcoming events.  Register now
Prescribing Information

News & Events

Registration

Register now to stay updated on clinical information related to Tasigna. You’ll also be notified about upcoming events, recent publications, and the latest research in Ph+ CML.

CML and Hematological Malignancies Newsletter

Read news briefs on the latest research in CML and other hematological malignancies.

Tasigna E-Newsletter

View the most recent clinical data coming from of ongoing Tasigna trials.

Recent Publications

See a list of the most recent publications related to CML, with links to online abstracts.



back to top


Disclaimer: This is an international website for Tasigna® (nilotinib)and is intended for healthcare professionals outside the US. If you are a US resident, please click on the US Residents link at the top of this page. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.

Home | About Tasigna | Ph + CML Information | For Your Patients | News & Events | Resources | Product Information
About Novartis Oncology | Privacy Information | Site Map | Contact Us

Use of this website is subject to our Terms of Use.
© 2010 Novartis AG